Solutions
Online Inquiry
Global Services. (Creative Biolabs Authorized)

Transposons Transfection Services

Online Inquiry

The field of genetic engineering is continuously evolving, moving beyond the limitations of early viral and non-viral delivery systems. While CRISPR-Cas technologies have revolutionized targeted gene editing, the challenge of achieving stable, long-term, and high-efficiency genomic integration of large transgenes remains a significant hurdle in both basic research and therapeutic development. Viral vectors, though efficient, are often constrained by cargo size, immunogenicity, and complex production logistics. Non-viral methods like lipofection or electroporation frequently result in transient expression, limiting their utility for applications requiring sustained genetic modification. At Creative Biolabs, with over two decades of pioneering work in molecular and cell biology, we have perfected the art and science of transposon-based gene delivery.

Schematic design of the transposon systems (PB, SB, and Tol2) application in bovine somatic and germ cellFig.1 Schematic design of the transposon systems (PB, SB, and Tol2) application in bovine somatic and germ cell1,2

Our suite of Transposons Transfection Services provides a robust, versatile, and scalable platform to overcome these challenges, enabling seamless genomic integration for your most ambitious cellular engineering projects.

Our Comprehensive Service Portfolio

We offer an end-to-end solution, tailoring our services to meet the specific needs of each client's project, from initial vector design to final clone validation.

Custom Transposon Vector Construction

  • Design & Cloning: Our experts will design and clone your gene of interest (GOI) into optimized transposon donor vectors. We offer a library of backbones with various promoters (constitutive, inducible, tissue-specific), selectable markers (e.g., puromycin, neomycin, blasticidin), and reporter genes (e.g., GFP, luciferase)
  • Cargo Flexibility: Capable of accommodating large and complex genetic cargos, including multiple gene expression cassettes and regulatory elements, surpassing the limitations of many viral systems

Cell Line Transfection & Selection

  • Cell Line Expertise: We perform transfections on a wide range of cell types, including standard immortalized lines (HEK293, HeLa), primary cells, and sensitive stem cells.
  • Optimized Delivery: We employ the most effective transfection method (e.g., electroporation, lipofection) for your specific cell type to maximize delivery efficiency while maintaining high cell viability.
  • Stable Pool Generation: Following transfection with the transposon and transposase, cells are placed under appropriate antibiotic selection to generate a polyclonal population of stably transfected cells.

Single-Cell Clone Isolation & Expansion

  • Limiting Dilution & FACS: We isolate single-cell clones via limiting dilution or fluorescence-activated cell sorting (FACS) to ensure clonal purity.
  • Expansion & Banking: Selected clones are expanded, and master and working cell banks are created for long-term storage and future use.

Comprehensive Molecular Validation

  • Genomic Integration Analysis: Verification of transgene integration via PCR and Southern blotting to confirm copy number and pattern.
  • Expression Profiling: Quantification of transgene expression at the mRNA (qRT-PCR) and protein (Western blot, flow cytometry, immunofluorescence) levels.
  • Functional Assays: Custom functional assays can be developed to confirm the biological activity of the integrated transgene.

Why Partner with Creative Biolabs? The Definitive Advantages

Choosing our services provides you with a strategic edge, grounded in scientific excellence and operational reliability.

Unparalleled Expertise: Our team of PhD-level scientists brings over 20 years of direct experience in transposon biology, vectorology, and cell line development. We navigate complex project challenges with proven strategies.

Superior Integration Efficiency: Our proprietary formulations of hyperactive transposase systems (e.g., SB100X, piggyBac variants) ensure exceptionally high integration rates, leading to a greater yield of stable clones.

Precision and Footprint-Free Engineering: A key differentiator of our piggyBac-based services is the ability to perform "footprint-free" excision, allowing for clean removal of the transgene, which is invaluable for iPSC reprogramming and reversible genetic studies.

Robust and Scalable Process: From a small-scale research project to GMP-compatible manufacturing for pre-clinical studies, our processes are designed for scalability and reproducibility.

Integrated, End-to-End Support: We are your single point of contact for the entire project lifecycle, from conceptual design to the delivery of validated, banked cell lines, saving you time and streamlining internal resources.

Our Streamlined Project Workflow

We believe in transparency and clear communication throughout our collaboration.

Consultation & Project Scoping

We begin with a detailed discussion to understand your goals, target cell line, and desired deliverables. A comprehensive project proposal and timeline are provided

Vector Design & Construction

Our team designs the optimal transposon construct and proceeds with molecular cloning, followed by rigorous QC (sequencing, restriction digest)

Co-transfection & Selection

The validated transposon vector and transposase mRNA/plasmid are co-delivered into your target cells. Cells are then transitioned to selection media to establish a stable polyclonal pool

Clone Isolation & Screening

Single-cell clones are isolated and expanded. These clones are screened using high-throughput methodologies to identify top candidates with the desired integration and expression profile

Analytical Validation & Delivery

The lead clones undergo in-depth molecular and functional validation. Upon your final review, the validated cell lines and a comprehensive project report are delivered.

Diverse Applications Across Biotechnology

Our Transposon Transfection Services are a foundational technology with broad applicability.

Stable Cell Line Development
For high-yield recombinant protein production (e.g., antibodies, vaccines) and long-term functional studies
Gene and Cell Therapy Research
Engineering of CAR-T cells, stem cells, and other therapeutic cell types with stable transgene expression for pre-clinical development
Functional Genomics & Screens
Creating genome-wide lentiviral-transposon hybrid libraries for high-throughput gain-of-function or loss-of-function genetic screens.
Induced Pluripotent Stem Cell (iPSC) Engineering
Safe and efficient integration of reprogramming factors or corrective genes into patient-derived iPSCs.
Disease Modeling
Generating isogenic cell lines with specific disease-associated mutations to study pathogenesis and identify novel therapeutics.

Client Testimonials: Evidence of Excellence

  • "Creative Biolabs's piggyBac service was instrumental in generating our master cell line for a complex bispecific antibody. Their team's expertise in handling large DNA constructs and their rigorous clone screening process saved us months of internal work. The resulting cell line shows exceptional stability and productivity." – Director of Cell Line Development, Biopharma
  • "We engaged Creative Biolabs to engineer patient-derived iPSCs for a rare disease model. Their ability to achieve high-efficiency, footprint-free integration of our reporter construct was exactly what we needed. The scientific collaboration and support throughout the project were outstanding." – Principal Investigator, Academic Research Institute
  • "We struggled for months with low efficiency in primary T-cells. Creative Biolabs's optimized transfection protocol delivered the high-efficiency, stable CAR integration we needed for our pre-clinical models, with exceptional cell viability." – Project Lead, Cell Therapy Biotech
  • "Their team's deep expertise in piggyBac technology was the differentiator. The precise, footprint-free excision in our iPSC line was flawless, enabling a critical phase of our regenerative medicine program." – Research Fellow, Academic Medical Center
  • "Outstanding service from start to finish. The comprehensive molecular data provided with the final clonal cell line gave us complete confidence in the model for our high-throughput screening campaign." – Head of Oncology Discovery

Addressing Your Scientific Inquiries

What is the primary advantage of using transposon systems over lentiviral transduction for stable cell line generation?

Transposon systems offer a non-viral alternative, eliminating concerns related to viral vector biosafety, immunogenicity, and the inherent limitations on cargo size. They provide a more straightforward and cost-effective production path, especially for large or complex genetic constructs, while still achieving high-efficiency, long-term genomic integration.

Can your service handle difficult-to-transfect cell types, such as primary cells or neurons?

A: Absolutely. We have developed specialized proprietary protocols and optimized delivery conditions for a wide spectrum of challenging cell types, including primary cells, stem cells, and neurons. Our initial project consultation includes a feasibility assessment to determine the optimal strategy for your specific cell line.

How do you manage the risk of insertional mutagenesis or transgene silencing?

We employ several strategies to mitigate these risks. Our hyperactive transposases promote a more random integration profile, reducing the likelihood of genotoxicity compared to some viral vectors. Furthermore, we utilize donor vectors equipped with chromatin insulators and CpG-methylation minimized backbones to significantly enhance the long-term stability of transgene expression and prevent epigenetic silencing.

What level of characterization and data can I expect upon project completion?

You will receive a final project report that includes detailed documentation of the vector design, full sequencing data, copy number analysis (e.g., via qPCR or Southern blot), and comprehensive expression data (e.g., flow cytometry histograms, Western blot images). We deliver the fully characterized cell clones and their associated banks.

References

  1. Kwon, Dong-Hyeok et al. "Application of transposon systems in the transgenesis of bovine somatic and germ cells." BMC veterinary research vol. 18,1 156. 27 Apr. 2022, https://doi.org/10.1186/s12917-022-03252-1
  2. Distributed under Open Access license CC BY 4.0, without modification.
Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Key Updates
Newsletter. (Creative Biolabs Authorized) NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution. (Creative Biolabs Authorized) NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
Novel Solution. (Creative Biolabs Authorized) NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
New Technology. (Creative Biolabs Authorized) NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.